Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 786† | 703† | 639† | 649† | 669† |
| Net profit | 97 | 69 | 51 | 85 | 93† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Narsimha Shibroor Kamath | Executive Director | June 30, 2026 |
| Deepak Rameshchandra Shah | Independent Director | June 30, 2026 |
| Nandkumar Kashinath Chodankar | Independent Director | June 30, 2026 |
| Shilpa Vinodkumar Bhatia | Independent Director | June 30, 2026 |
| Vijayanarayanan Mahadevan | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
